Ledger.Open graph →
SEC Form D · filed September 30, 2013

Celsus Therapeutics Plc

Offering
$12.5M
Sold
$12.5M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
LONDON, United Kingdom
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (16)

Saul Yedgar · Jerusalem, L3Exec · DirectorTerry L. Meadors · Cincinnati, OHDirectorAmos Eiran · Herzeliya, L3DirectorDov Elefant · New York, NYExecMark Cohen · Washington, Washington, D.C.DirectorFredric Price · London, United KingdomDirectorMaziyar Yousefizad · Gainesville, FLDirectorThomas Alessi · Hayward, CAExec · DirectorAllan Haims · North Hollywood, CADirectorGur Roshwalb · London, United KingdomExecDov Elefant · London, United KingdomExecMark Cohen · London, United KingdomDirectorDavid Sidransky · Somerset, NJDirectorAlan Harris · New York, NYExecRobert Doman · London, United KingdomDirectorFredric Price · TEL AVIV, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗